These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 17633096)

  • 1. [2-year complete remission after withdrawal of methotrexate in a rectal methotrexate-associated diffuse large B-cell lymphoma].
    Ogasawara T; Kimura A; Yasuyama M; Ohtuka K; Aiba M; Kawauchi K
    Rinsho Ketsueki; 2007 Jun; 48(6):485-90. PubMed ID: 17633096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
    Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
    J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis].
    Pastor-Nieto MA; Kilmurray LG; López-Chumillas A; O'Valle F; García-Del Moral R; Puig AM; Bautista P
    Actas Dermosifiliogr; 2009 Mar; 100(2):142-6. PubMed ID: 19445880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
    Hatanaka K; Nakamura N; Kojima M; Ando K; Irie S; Bunno M; Nakamine H; Uekusa T
    Pathol Res Pract; 2010 Jan; 206(1):9-13. PubMed ID: 19628340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
    Miyazaki T; Fujimaki K; Shirasugi Y; Yoshiba F; Ohsaka M; Miyazaki K; Yamazaki E; Sakai R; Tamaru J; Kishi K; Kanamori H; Higashihara M; Hotta T; Ishigatsubo Y
    Am J Hematol; 2007 Dec; 82(12):1106-9. PubMed ID: 17654684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
    Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
    Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoma in a patient with rheumatoid arthritis receiving methotrexate treatment: successful treatment with rituximab.
    Stewart M; Malkovska V; Krishnan J; Lessin L; Barth W
    Ann Rheum Dis; 2001 Sep; 60(9):892-3. PubMed ID: 11502618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection.
    Lioté F; Pertuiset E; Cochand-Priollet B; D'Agay MF; Dombret H; Numéric P; D'Anglejan G; Kuntz D
    J Rheumatol; 1995 Jun; 22(6):1174-8. PubMed ID: 7674250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
    Maruani A; Wierzbicka E; Machet MC; Abdallah-Lotf M; de Muret A; Machet L
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S69-71. PubMed ID: 17938029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.
    Yamada K; Oshiro Y; Okamura S; Fujisaki T; Kondo S; Nakayama Y; Suematsu E; Tamura K; Takeshita M
    Histopathology; 2015 Jul; 67(1):70-80. PubMed ID: 25429725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-associated synovial lymphoma in a chronically inflamed joint in rheumatoid arthritis receiving prolonged methotrexate treatment.
    Chim CS; Pang YY; Ooi GC; Mok MY; Shek TW
    Haematologica; 2006 Aug; 91(8 Suppl):ECR31. PubMed ID: 16923515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate.
    Sibilia J; Lioté F; Mariette X
    Rev Rhum Engl Ed; 1998 Apr; 65(4):267-73. PubMed ID: 9599795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
    Quartuccio L; De Re V; Fabris M; Marzotto A; Franzolini N; Gasparotto D; Caggiari L; Ferraccioli G; Scott CA; De Vita S
    Haematologica; 2006 May; 91(5):691-4. PubMed ID: 16670074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
    Hsiao SC; Ichinohasama R; Lin SH; Liao YL; Chang ST; Cho CY; Chuang SS
    Pathol Res Pract; 2009; 205(1):43-9. PubMed ID: 18951733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.
    Paul C; Le Tourneau A; Cayuela JM; Devidas A; Robert C; Molinié V; Dubertret L
    Arch Dermatol; 1997 Jul; 133(7):867-71. PubMed ID: 9236525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoma with regression after methotrexate withdrawal in a patient with rheumatoid arthritis. Role for the Epstein-Barr virus.
    Le Goff P; Chicault P; Saraux A; Baron D; Valls-Bellec I; Leroy JP
    Rev Rhum Engl Ed; 1998 Apr; 65(4):283-6. PubMed ID: 9599798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis.
    Fam AG; Perez-Ordonez B; Imrie K
    J Rheumatol; 2000 Jun; 27(6):1546-9. PubMed ID: 10852288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
    Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
    Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
    Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
    J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.